Srinivas Akkaraju - 15 Nov 2021 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role
Director
Signature
/s/ Srinivas Akkaraju
Issuer symbol
N/A
Transactions as of
15 Nov 2021
Net transactions value
+$17,010,000
Form type
4
Filing time
17 Nov 2021, 11:05:49 UTC
Previous filing
27 Sep 2021
Next filing
27 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KDNY Common Stock Purchase $17,010,000 +1,215,000 +36% $14.00 4,591,888 15 Nov 2021 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a purchase from the underwriters in a public offering of the issuer.
F2 Shares held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The reporting person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person's pecuniary interest therein.